SVP, US Medical Aesthetics
David Moatazedi has been with Allergan (AGN) for over 12 years and currently serves as Senior Vice President, US Medical Aesthetics. In this position, David is responsible for the Facial injectable, Plastic Surgery, Body Contouring and Skincare franchises with market leading brands including Botox® Cosmetic, JUVEDERM® Collection, CoolSculpting® KYBELLA®, SkinMedica®, Latisse® and Natrelle®.
Mr. Moatazedi has over seventeen years’ commercial experience managing upstream and downstream marketing, working across multiple brands with increasing responsibility. David has also led several acquisitions including the recent acquisition of LifeCell for $2.9B and Zeltiq for $2.5B. Most recently, David was appointed to the board of Obalon Therapeutics (OBLN).
Prior to joining Allergan, David spent six years working for Novartis Pharmaceuticals in various sales roles. He holds an MBA in Marketing from Pepperdine University and a BA Degree in Chemistry from California State University, Long Beach. David resides in Newport Beach with his wife and three children.